| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Management > Why Would Anyone Do That in My Meeting? |
|
Main Subject - Why Would Anyone Do That in My Meeting?
Imagine that you open a meeting by saying, "We need to talk about the budget." And someone responds with, "I named my dog Budget because everyone tells me he's too big." After the laughter subsides, you wonder why anyone According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product would make such a silly remark
in your meeting. And this leads to a larger question: Why would anyone misbehave in a meeting? Taken to the extreme, misbehavior can ruin a meeting. That wastes everyone's time and squa ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ders the opportunity to produce useful results. Here are some possibilities. 1) They're uninformed Many people do not know how to plan, conduct, or participate in a meeting. They think that gathering people in a confere lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. nce room represents holding a meeting.
They believe that planning is unnecessary because they expect everyone to arrive
with a common agenda. They think that hosting a discussion actually leads to useful
results. These here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe well-meaning attempts at holding a meeting are so
counterproductive that they can appear to be misbehavior. In addition, a bad
meeting irritates others, causing them to retaliate with misbehavior. Better: Show people ho d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro to plan and conduct meetings. Teach them how to use
process tools that help people make methodical progress toward results. Schedule a
workshop that shows people how to plan and lead meetings. (Call me to talk about
m ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc y outstanding workshop.) 2) They're bored. Many meetings occur with a few people talking while the rest watch. When this happens, the quiet participants entertain themselves by daydreaming, starting side conversations, easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi or working on other tasks (such as preparing lists of things to do
once the meeting finally ends). People with extensive experience in bad meetings
have learned how to feign credible interest while being mentally absent. nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically Better: Plan activities that involve everyone. Avoid relying on discussion for your meeting because it allows the more vocal attendees to dominate. 3) They're mad. People can be mad for many reasons, such as they feel and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ rapped in an unplanned
meeting or they disagree with the results being obtained. They could also feel mad
if others are preventing them from participating. People know that a meeting without an agenda will waste their t ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi me, and they resent
this. For example, a man once told me that he and his friends would "sandbag" any
meeting that was called without an agenda. They made inappropriate comments,
introduced distracting considerations, ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a and asked pointless questions. Of course,
they acted with such professional sincerity that it seemed that they were being
productive instead of disruptive. Better: Always prepare an agenda. Always contact key participan dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod s before the
meeting to explain their role and to check if they are prepared for the meeting. 4) They disagree Meetings are an excellent activity to resolve disagreements. However, if people disagree with the issue, th cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin e process, or the results AND are unable to exert
influence, they will rebel. This rebellion will appear as misbehavior in the meeting or
(worse) sabotage after the meeting. Better: Use process tools in the meeting that tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen involve all of the participants. Always
contact key participants before holding a meeting on a controversial issue. Use
these conversations to listen to their views, explain the goals for the meeting, and
promote your t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ntent for a fair resolution. Make sure that you seek a "Both/And"
result instead of an "Either/Or" result so that everyone gets what they need. 5) They misunderstand Sometimes people misunderstand expectations. For examp ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust le, an executive was
surprised by the negative comments, ridicule, and hostility that occurred during his
first staff meeting with a new group. After some investigation, he learned that his
predecessor openly criticize y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products and ridiculed people. Thus, this was the behavior that
the staff had learned to emulate. The executive fixed this by a) stating new
expectations, b) coaching key offenders, and c) setting an example of respectful
cond . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de uct. Better: Cultural management is a primary leadership responsibility. Demonstrate the type of behavior that you want for productive meetings and provide private corrective feedback to those who misbehave. An effecti elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip e meeting is a team activity conducted by a fair process that involves
everyone. People respect this approach and will make positive contributions because
they know that such a meeting represents a good use of their time tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:What To Do After You've Been Betrayed Tales From the Corporate Frontlines: Here Today, Gone Tomorrow Are Your Frequent Customers Freeloaders, Scoundrels or Cheats
|